What Caught Our Attention in the Investment World? – Week of October 21-25, 2019
By Kuldip K. Ambastha and Anil K. Ambastha On October 22, 2019, Biogen Inc. (BIIB) delivered a 26.1% return for the day. This was the stock’s largest one-day percentage return in 23 years. Its Alzheimer’s drug (aducanumab) had previously been written off as a failure, but now will be getting a second chance at approval …
Continue reading “What Caught Our Attention in the Investment World? – Week of October 21-25, 2019”